For-Robin Overview
- Founded
-
2012

- Status
-
Private
- Employees
-
2

- Latest Deal Type
-
Accelerator/Inc
- Investors
-
4
For-Robin General Information
Description
Developer of immunotherapies for breast cancer treatment. The company develops treatments primarily for breast and lung cancer patients that, utilizing proprietary technology, target all breast and lung cancer cell subtypes including triple-negative breast cancer where no targeted therapy currently exists, enabling healthcare providers to improve outcomes for cancer patients.
Contact Information
Website
www.for-robin.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 97 Troyview Lane
- Williamsville, NY 14221
- United States
For-Robin Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Accelerator/Incubator | 02-Jun-2015 | Completed | Startup | |||
3. Grant | 04-May-2015 | 000 | Completed | Startup | ||
2. Grant | 01-Jan-2013 | $363K | Completed | Startup | ||
1. Grant | $464K | Completed | Startup |
For-Robin Executive Team (3)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Sally Quataert Ph.D | Chief Executive Officer | ||
Kate Rittenhouse-Olson Ph.D | Founder, President & Chief Strategy Officer | ||
James Olson Ph.D | Chairman & Vice President |
For-Robin Board Members (1)
Name | Representing | Role | Since |
---|---|---|---|
James Olson Ph.D | For-Robin | Chairman & Vice President | 000 0000 |
For-Robin Signals
For-Robin Investors (4)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Start-up NY | Accelerator/Incubator | 000 0000 | 000000 0 | ||
National Institutes of Health | Government | 000 0000 | 000000 0 | ||
Boston University Endowment | Limited Partner | 000 0000 | 000000 0 | ||
National Cancer Institute | Government | 000 0000 | 000000 0 |